|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions decreases activity |
ISO |
Saquinavir inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Saquinavir results in decreased activity of ABCB11 protein |
CTD |
PMID:20829430 PMID:23956101 PMID:24014644 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases export affects export affects uptake |
ISO |
ABCB1 protein results in increased export of Saquinavir ABCB1 protein affects the export of Saquinavir ABCB1A protein affects the uptake of Saquinavir |
CTD |
PMID:10562306 PMID:15832500 PMID:18535159 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
affects uptake |
ISO |
ABCB1B protein affects the uptake of Saquinavir |
CTD |
PMID:10562306 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases export |
ISO |
ABCC1 protein results in increased export of Saquinavir |
CTD |
PMID:18535159 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects export increases export multiple interactions |
ISO |
ABCC2 protein affects the export of Saquinavir ABCC2 protein results in increased export of Saquinavir montelukast inhibits the reaction [ABCC2 protein results in increased export of Saquinavir]; verlukast inhibits the reaction [ABCC2 protein results in increased export of Saquinavir] |
CTD |
PMID:15832500 PMID:18535159 PMID:19952419 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases expression multiple interactions |
ISO |
Saquinavir results in decreased expression of ADIPOQ mRNA; Saquinavir results in decreased expression of ADIPOQ protein [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA; rosiglitazone inhibits the reaction [Saquinavir results in decreased secretion of ADIPOQ protein] |
CTD |
PMID:15865214 PMID:16931933 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Aebp1 |
AE binding protein 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of AEBP1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Saquinavir binds to ALB protein |
CTD |
PMID:15814459 PMID:16336266 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ALOX5AP mRNA |
CTD |
PMID:16931933 |
|
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
|
|
G |
Arpp21 |
cAMP regulated phosphoprotein 21 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ARPP21 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 8:112,034,636...112,199,273
Ensembl chr 8:112,034,642...112,194,297
|
|
G |
Asic2 |
acid sensing ion channel subunit 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ASIC2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:65,870,592...66,940,577
Ensembl chr10:65,870,594...66,940,424
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
ISO |
Saquinavir results in increased expression of ATF6 protein |
CTD |
PMID:19147209 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
C1r |
complement C1r |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C1R mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
|
|
G |
C3ar1 |
complement C3a receptor 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of C3AR1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
Casp9 |
caspase 9 |
increases cleavage |
ISO |
Saquinavir results in increased cleavage of CASP9 protein |
CTD |
PMID:19147209 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CD36 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cfd |
complement factor D |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CFD mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CIDEC mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of CLCN3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr16:29,127,152...29,200,133
Ensembl chr16:29,127,419...29,200,119
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
Saquinavir inhibits the reaction [Morphine results in increased expression of CYBB protein] |
CTD |
PMID:14871405 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
Saquinavir results in increased expression of CYP1A1 mRNA |
CTD |
PMID:9860486 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases metabolic processing decreases activity |
ISO |
Glutathione inhibits the reaction [Saquinavir results in decreased activity of CYP3A4 protein] CYP3A4 protein results in increased metabolism of Saquinavir |
CTD |
PMID:11824416 PMID:15523003 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dcn |
decorin |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DCN mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Dusp3 |
dual specificity phosphatase 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of DUSP3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ELOVL3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 1:244,997,287...245,001,115
Ensembl chr 1:244,997,287...245,001,115
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ESR2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ETV6 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:166,849,031...167,085,211
Ensembl chr 4:166,847,686...167,084,992
|
|
G |
Fads2 |
fatty acid desaturase 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of FADS2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Faim |
Fas apoptotic inhibitory molecule |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of FAIM mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 8:99,543,877...99,569,499
Ensembl chr 8:99,542,405...99,560,562
|
|
G |
G0s2 |
G0/G1switch 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of G0S2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
Ganc |
glucosidase, alpha; neutral C |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of GANC mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 3:107,353,369...107,406,104
Ensembl chr 3:107,353,369...107,405,241
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of GUCY1B1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of HADH mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
|
|
G |
Hcn1 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of HCN1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of H4C9 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
Saquinavir results in increased expression of HSPA5 protein |
CTD |
PMID:19147209 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Ikzf4 |
IKAROS family zinc finger 4 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of IKZF4 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 7:1,063,283...1,102,940
Ensembl chr 7:1,056,890...1,084,341
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
Saquinavir results in increased expression of IL6 mRNA; Saquinavir results in increased expression of IL6 protein Saquinavir inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] rosiglitazone inhibits the reaction [Saquinavir results in increased expression of IL6 mRNA] |
CTD |
PMID:15388451 PMID:15865214 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
Saquinavir inhibits the reaction [INS protein results in increased import of Glucose] |
CTD |
PMID:11786383 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Klhl28 |
kelch-like family member 28 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of KLHL28 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 6:82,987,360...83,018,971
Ensembl chr 6:82,990,945...83,016,164
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of LAMC2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEF1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of LEP mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lpl |
lipoprotein lipase |
decreases activity decreases expression |
ISO |
Saquinavir results in decreased activity of LPL protein Saquinavir results in decreased expression of LPL mRNA |
CTD |
PMID:11741158 PMID:11786383 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Me1 |
malic enzyme 1 |
decreases expression |
ISO |
Saquinavir results in decreased expression of ME1 mRNA |
CTD |
PMID:11741158 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mgat4c |
MGAT4 family, member C |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MGAT4C mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 7:36,709,564...37,485,810
Ensembl chr 7:37,260,321...37,474,571
|
|
G |
Mrap |
melanocortin 2 receptor accessory protein |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of MRAP mRNA |
CTD |
PMID:16931933 |
|
NCBI chr11:29,991,974...30,003,024
Ensembl chr11:29,992,034...30,003,024
|
|
G |
Myod1 |
myogenic differentiation 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of MYOD1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
|
|
G |
Nap1l5 |
nucleosome assembly protein 1-like 5 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NAP1L5 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:88,022,670...88,024,988
Ensembl chr 4:88,022,569...88,024,654
|
|
G |
Noct |
nocturnin |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of NOCT mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
|
|
G |
Notch4 |
notch receptor 4 |
multiple interactions decreases expression |
EXP |
[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of NOTCH4 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of NOTCH4 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of NOTCH4 protein] Saquinavir results in decreased expression of NOTCH4 protein |
CTD |
PMID:20722969 |
|
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
NR1I2 gene promotes the reaction [Rifampin results in increased metabolism of Saquinavir] |
CTD |
PMID:18799805 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nup210 |
nucleoporin 210 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of NUP210 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 4:123,511,558...123,609,874
Ensembl chr 4:123,511,559...123,609,874
|
|
G |
Oaz3 |
ornithine decarboxylase antizyme 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of OAZ3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:182,073,212...182,076,147
Ensembl chr 2:182,073,215...182,082,399
|
|
G |
Pcdh15 |
protocadherin related 15 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PCDH15 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr20:13,997,094...15,496,446
Ensembl chr20:13,963,565...15,494,719
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PFKFB3 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr17:66,983,629...67,064,702
Ensembl chr17:66,983,686...67,063,125
|
|
G |
Phf6 |
PHD finger protein 6 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of PHF6 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr X:132,656,658...132,699,720
Ensembl chr X:132,656,672...132,699,127
|
|
G |
Pidd1 |
p53-induced death domain protein 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIDD1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
|
|
G |
Piwil2 |
piwi-like RNA-mediated gene silencing 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PIWIL2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
|
|
G |
Pon1 |
paraoxonase 1 |
decreases activity |
EXP |
Saquinavir results in decreased activity of PON1 protein |
CTD |
PMID:27378623 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Porcn |
porcupine O-acyltransferase |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PPN mRNA |
CTD |
PMID:16931933 |
|
NCBI chr X:14,285,864...14,298,481
Ensembl chr X:14,285,871...14,298,481
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of POU5F1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Prdm1 |
PR/SET domain 1 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of PRDM1 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
|
|
G |
Reep6 |
receptor accessory protein 6 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of REEP6 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
|
|
G |
Rnf151 |
ring finger protein 151 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of RNF151 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:13,742,682...13,747,192
Ensembl chr10:13,742,682...13,745,000
|
|
G |
Rpain |
RPA interacting protein |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of RPAIN mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:55,692,410...55,699,910
Ensembl chr10:55,692,417...55,699,933
|
|
G |
RT1-CE5 |
RT1 class I, locus CE5 |
affects expression |
ISO |
Saquinavir affects the expression of HLA-F mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:3,403,418...3,479,476
|
|
G |
RT1-DOa |
RT1 class II, locus DOa |
affects expression |
ISO |
Saquinavir affects the expression of HLA-DOA mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,753,598...4,756,577
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of S100A8 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
affects uptake |
ISO |
SLCO1A2 protein affects the uptake of Saquinavir |
CTD |
PMID:15832500 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
Saquinavir inhibits the reaction [Morphine results in increased expression of SOD2 protein] |
CTD |
PMID:14871405 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spink5 |
serine peptidase inhibitor, Kazal type 5 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SPINK5 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr18:36,264,452...36,333,143
Ensembl chr18:36,264,452...36,332,185
|
|
G |
Sv2b |
synaptic vesicle glycoprotein 2b |
affects response to substance |
ISO |
SV2B gene SNP affects the susceptibility to Saquinavir |
CTD |
PMID:25622337 |
|
NCBI chr 1:128,978,471...129,152,479
Ensembl chr 1:128,978,473...129,152,479
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TIMP2 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions decreases expression |
EXP |
[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of TJP1 protein] Saquinavir results in decreased expression of TJP1 protein |
CTD |
PMID:20722969 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
Saquinavir inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] rosiglitazone inhibits the reaction [Saquinavir results in increased expression of TNF mRNA] Saquinavir results in increased expression of TNF mRNA; Saquinavir results in increased expression of TNF protein |
CTD |
PMID:15388451 PMID:15865214 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trim42 |
tripartite motif-containing 42 |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of TRIM42 mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 8:97,902,349...97,923,268
Ensembl chr 8:97,902,353...97,923,268
|
|
G |
Wnt10a |
Wnt family member 10A |
multiple interactions |
ISO |
[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of WNT10A mRNA |
CTD |
PMID:16931933 |
|
NCBI chr 9:76,349,931...76,362,400
Ensembl chr 9:76,349,931...76,362,400
|
|